Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 4, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 6, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001022079-26-000028
Filed / recorded
Mar 6, 2026, 9:44 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
QUEST DIAGNOSTICS INC
Issuer CIK
1022079
Ticker
DGX
Reporting person
J. E. Davis
Relationship
Director, Officer
Officer title
CEO and President
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Mar 4, 2026
Transaction code
A
Shares / units
51,652
Price per share
$204.86
Acquired / disposed
Acquired (A)
Shares owned after
168,837
Ownership form
Direct
Amendment
No
Footnotes from the filing
Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).